Over-the-counter treatments are widely available, but ophthalmologists warn the potential side effects can be harmful.
The DURYSTA market potential seems strong due to the increasing prevalence of glaucoma, the need for long-term, non-adherence-dependent treatments, and its advantage over daily eye drops. With an ...
It contains the prostaglandin analog bimatoprost. Other over-the-counter-products — GrandeLash, RevitaLash — are not FDA-approved (that’s not to say they’re unlicensed, just that they’ve ...
Purpose: We investigated the intraocular pressure (IOP) variations after switching from 0.005% latanoprost to 0.01% bimatoprost in open-angle glaucoma patients who experienced IOP elevation during ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果